Search Filters
Format Format
Subjects Subjects
Subjects Subjects
Sort by Item Count (A-Z)
Filter by Count
index medicus (9) 9
carcinoma, non-small-cell lung - drug therapy (6) 6
chemotherapy (6) 6
humans (6) 6
lung cancer (6) 6
lung neoplasms - drug therapy (6) 6
oncology (6) 6
female (5) 5
male (5) 5
middle aged (5) 5
respiratory system (5) 5
aged (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
disease-free survival (4) 4
lung neoplasms - pathology (4) 4
abridged index medicus (3) 3
adult (3) 3
analysis (3) 3
carboplatin (3) 3
docetaxel (3) 3
experiment (3) 3
gefitinib (3) 3
ligands (3) 3
metastasis (3) 3
mutation (3) 3
nivolumab (3) 3
non-small-cell lung cancer (3) 3
nuclear experiment (3) 3
patients (3) 3
physics (3) 3
predictive value of tests (3) 3
survival (3) 3
tumors (3) 3
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (2) 2
[phys.nexp]physics [physics]/nuclear experiment [nucl-ex] (2) 2
aged, 80 and over (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
apoptosis (2) 2
cancer therapies (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
care and treatment (2) 2
cisplatin (2) 2
clinical investigations (2) 2
clinical outcomes (2) 2
clinical trials (2) 2
computer science (2) 2
drug administration schedule (2) 2
erlotinib (2) 2
erlotinib hydrochloride (2) 2
etoposide (2) 2
high energy physics - experiment (2) 2
histology (2) 2
immunotherapy (2) 2
kaplan-meier estimate (2) 2
lung cancer, non-small cell (2) 2
lung neoplasms - mortality (2) 2
medicine, general & internal (2) 2
motivation (2) 2
mutations (2) 2
nanomaterialien (2) 2
nanoparticles (2) 2
nanotubes (2) 2
paclitaxel (2) 2
particle physics (2) 2
platinum (2) 2
prognosis (2) 2
proportional hazards models (2) 2
randomization (2) 2
risk assessment (2) 2
survival analysis (2) 2
taxoids - administration & dosage (2) 2
therapy (2) 2
114 physical sciences (1) 1
algorithms (1) 1
alice (1) 1
alice experiment (1) 1
alice; heavy-ion collisions; lhc; particle detectors (1) 1
alice; lhc; relativistic heavy ions (1) 1
alphaproteobacteria (1) 1
amino acid sequence (1) 1
anaplastic lymphoma kinase - drug effects (1) 1
anaplastic lymphoma kinase - genetics (1) 1
annealing (1) 1
anode material (1) 1
anode-materials (1) 1
anodenwerkstoff (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antibody mpdl3280a (1) 1
anticodon nuclease (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
aqueous solutions (1) 1
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range

Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10066, pp. 255 - 265
Journal Article
by Mok, Tony and Mok, Tony S K and Wu, Yilong and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Kowalski, Dariusz and Cho, Byoung Chul and Turna, Hande and Turna, Hande Z and Castro, Hugo and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Zhang, Li and Zhang, Xin and Kush, Debra and Lopes, Valeria and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Xi and Chen, Gongyan and Cheng, Ying and Cheng, Susanna and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Yong and He, Jianxing and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | BEVACIZUMAB | CRIZOTINIB | NIVOLUMAB | PACLITAXEL | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Slopes | Lung cancer | Oncology | Kinases | Cancer therapies | Metastases | Pembrolizumab | Randomization | Motivation | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Hypothyroidism | Survival | Patients | Medical centres | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis
Journal Article
by Paz-Ares, Luis and Dvorkin, Mikhail and Chen, Chengshui and Chen, Yen-Hsun and Chen, Yuan and Chen, Yuanbin and Chen, Zhendong and Reinmuth, Niels and Hotta, Katsuyuki and Trukhin, Dmytro and Statsenko, Galina and Hochmair, Maximilian J and Özgüroğlu, Mustafa and Ji, Jun Ho and Voitko, Nataliia and Voitko, Oleksandr and Poltoratskiy, Artem and Ponce, Santiago and Verderame, Francesco and Havel, Libor and Bondarenko, Igor and Kazarnowicz, Andrzej and Losonczy, György and Conev, Nikolay V and Armstrong, Jon and Byrne, Natalie and Shire, Norah and Jiang, Haiyi and Goldman, Jonathan W and Batagelj, Emilio and Casarini, Ignacio and Pastor, Anea Viviana and Sena, Susana Noemi and Zarba, Juan Jose and Burghuber, Otto and Hartl, Sylvia and Lamprecht, Bernd and Studnicka, Michael and Alberto Schlittler, Luis and Augusto Martinelli de Oliveira, Fabricio and Calabrich, Aknar and Colagiovanni Girotto, Gustavo and Dos Reis, Peo and Fausto Nino Gorini, Carlos and Rafael Martins De Marchi, Peo and Serodio da Rocha Baldotto, Clarissa and Sette, Claudia and Zukin, Mauro and Dudov, Assen and Ilieva, Rumyana and Koynov, Krassimir and Krasteva, Rositsa and Tonev, Ivan and Valev, Spartak and Venkova, Violetka and Bi, Minghong and Fang, Jian and Feng, Jifeng and Han, Zhigang and Hu, Jie and Hu, Yi and Li, Wei and Li, Chien-Te and Liang, Zongan and Lin, Zhong and Ma, Shenglin and Ma, Rui and Nan, Kejun and Shu, Yongqian and Wang, Chin-Chou and Wang, Kai and Wang, Mengzhao and Wu, Gang and Wu, Shang-Yin and Yang, Nong and Yang, Zhixiong and Zhang, Wei and Zhang, Helong and Zhao, Yanqiu and Zhao, Jun and Zhou, Jianying and Zhou, Caicun and Zhou, Xiangdong and Kolek, Vitezslav and Koubkova, Leona and Roubec, Jaromir and Skrickova, Jana and Zemanova, Milada and Chouaid, Christos and Hilgers, Werner and Lena, Hervé and Moro-Sibilot, Denis and Robinet, Gilles and Souquet, Pierre-Jean and Alt, Jürgen and Bischoff, Helge and Grohe, Christian and Laack, Eckart and Lang, Susanne and Panse, Jens and ...
The Lancet, ISSN 0140-6736, 11/2019, Volume 394, Issue 10212, pp. 1929 - 1939
Most patients with small-cell lung cancer (SCLC) have extensive-stage disease at presentation, and prognosis remains poor. Recently, immunotherapy has... 
Etoposide | Care and treatment | Product development | Lung cancer | Analysis | Drugs | Medical services | Radiation | Clinical trials | Metastasis | Cancer therapies | Randomization | Motivation | Platinum | Immunotherapy | Safety | Neutropenia | Small cell lung carcinoma | Maintenance | Radiation therapy | Survival | Patients | Cisplatin | Response rates | Carboplatin | Irradiation | Ligands | Clinical medicine | Solid tumors | Tumors | Apoptosis
Journal Article
by Meddi, F and Menchaca-Rocha, A and Meninno, E and Mercado Pérez, J and Meres, M and Miake, Y and Mikhaylov, K and Milano, L and Milosevic, J and Mischke, A and Mishra, A. N and Mis̈kowiec, D and Mitu, C. M and Mlynarz, J and Mohanty, B and Molnar, L and Montano Zetina, L and Montes, E and Morando, M and Moreira De Godoy, D. A and Moretto, S and Morreale, A and Morsch, A and Muccifora, V and Mudnic, E and Muhuri, S and Mukherjee, M and Müller, H and Munhoz, M. G and Murray, S and Musa, L and Musinsky, J and Nandi, B. K and Nania, R and Nappi, E and Nattrass, C and Nayak, T. K and Nazarenko, S and Nedosekin, A and Nicassio, M and Niculescu, M and Nielsen, B. S and Nikolaev, S and Nikulin, S and Nikulin, V and Nilsen, B. S and Noferini, F and Nomokonov, P and Nooren, G and Nyanin, A and Nystrand, J and Oeschler, H and Oh, S and Oh, S. K and Okatan, A and Olah, L and Oleniacz, J and Oliveira Da Silva, A. C and Onderwaater, J and Oppedisano, C and Ortiz Velasquez, A and Oskarsson, A and Twinowski, J and Oyama, K and Sahoo, P and Pachmayer, Y and Pachr, M and Pagano, P and Paić, G and Painke, F and Pajares, C and Pal, S. K and Palmeri, A and Pant, D and Papikyan, V and Pappalardo, G. S and Pareek, P and Park, W. J and Parmar, S and Passfeld, A and Patalakha, D. I and Paticchio, V and Paul, B and Pawlak, T and Peitzmann, T and Pereira Da Costa, H and Pereira De Oliveira Filho, E and Peresunko, D and Pérez Lara, C. E and Pesci, A and Pestov, Y and Petráček, V and Petran, M and Petris, M and Petrovici, M and Petta, C and Piano, S and Pikna, M and Pillot, P and Pinazza, O and ... and ALICE Collaboration and The ALICE Collaboration and Lund University and Partikelfysik and Lunds universitet and Particle Physics
International Journal of Modern Physics A, ISSN 0217-751X, 01/2014, Volume 29, Issue 24, p. 1430044
Journal Article
physica status solidi (a), ISSN 1862-6300, 04/2015, Volume 212, Issue 4, pp. 862 - 866
This work presents the results of high temperature annealing of iron nanowires at five different temperatures (ranging 200–800 °C) in the slightly oxidative... 
iron | magnetic properties | annealing | nanowires | NANOPARTICLES | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOTUBES | Annealing | Phase transformations | Aqueous solutions | Iron | Nanostructure | Nanowires | Magnetic fields | Magnetic properties
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 04/2019, Volume 14, Issue 4, pp. 701 - 711
Introduction: This phase II study evaluated the efficacy and safety of the pan-cyclin–dependent kinase inhibitor roniciclib with platinum-based chemotherapy in... 
Carboplatin | Etoposide | CDK inhibitor | Extensive-disease small cell lung cancer | Cisplatin | Roniciclib | TRIAL | CDK INHIBITORS | ONCOLOGY | RESPIRATORY SYSTEM | DEPENDENT KINASE INHIBITOR | CHEMOTHERAPY
Journal Article
Proceedings of the 6th International Workshop on foundations of mobile computing, 09/2010, pp. 13 - 22
In much of the theoretical literature on wireless algorithms, issues of message dissemination are considered together with issues of contention management.... 
multi-message broadcast | wireless network algorithms | MAC layer | contention management
Conference Proceeding
by Acharya, S and Acosta, FT and Adamova, D and Adhya, SP and Adler, A and Adolfsson, J and Aggarwal, MM and Rinella, GA and Agnello, M and Ahammed, Z and Ahmad, S and Ahn, SU and Aiola, S and Akindinov, A and Al-Turany, M and Alam, SN and Albuquerque, DSD and Aleksandrov, D and Alessandro, B and Alfanda, HM and Molina, RA and Ali, B and Ali, Y and Alici, A and Alkin, A and Alme, J and Alt, T and Altenkamper, L and Altsybeev, I and Anaam, MN and Andrei, C and Andreou, D and Andrews, HA and Andronic, A and Angeletti, M and Anguelov, V and Anson, C and Anticic, T and Antinori, F and Antonioli, P and Anwar, R and Apadula, N and Aphecetche, L and Appelshauser, H and Arcelli, S and Arnaldi, R and Arratia, M and Arsene, IC and Arslandok, M and Augustinus, A and Averbeck, R and Azmi, MD and Badala, A and Baek, YW and Bagnasco, S and Bailhache, R and Bala, R and Baldisseri, A and Ball, M and Baral, RC and Barbera, R and Barioglio, L and Barnafoldi, GG and Barnby, LS and Barret, V and Bartalini, P and Barth, K and Bartsch, E and Bastid, N and Basu, S and Batigne, G and Batyunya, B and Batzing, PC and Bauri, D and Alba, JLB and Bearden, IG and Bedda, C and Behera, NK and Belikov, I and Bellini, F and Martinez, HB and Bellwied, R and Beltran, LGE and Belyaev, V and Bencedi, G and Beole, S and Bercuci, A and Berdnikov, Y and Berenyi, D and Bertens, RA and Berzano, D and Betev, L and Bhasin, A and Bhat, IR and Bhatt, H and Bhattacharjee, B and Bianchi, A and Bianchi, L and Bianchi, N and Bielcik, J and ... and ALICE Collaboration and Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Computer Physics Communications, ISSN 0010-4655, 09/2019, Volume 242, Issue C, pp. 25 - 48
At the Large Hadron Collider at CERN in Geneva, Switzerland, atomic nuclei are collided at ultra-relativistic energies. Many final-state particles are produced... 
Journal Article
Chemotherapy, ISSN 0009-3157, 03/2012, Volume 58, Issue 1, pp. 60 - 69
Journal Article